Literature DB >> 25172503

Blood Type O is not associated with increased blood loss in extensive spine surgery.

Ryu Komatsu1, Jarrod E Dalton2, Michael Ghobrial3, Alexander Y Fu4, Jae H Lee3, Cameron Egan3, Daniel I Sessler3, Yusuke Kasuya5, Alparslan Turan3.   

Abstract

STUDY
OBJECTIVE: To investigate whether Type O blood group status is associated with increased intraoperative blood loss and requirement of blood transfusion in extensive spine surgery.
DESIGN: Retrospective comparative study.
SETTING: University-affiliated, non-profit teaching hospital. MEASUREMENTS: Data from 1,050 ASA physical status 1, 2, 3, 4, and 5 patients who underwent spine surgeries involving 4 or more vertebral levels were analyzed. Patients with Type O blood were matched to similar patients with other blood types using propensity scores, which were estimated via demographic and morphometric data, medical history variables, and extent of surgery. Intraoperative estimated blood loss (EBL) was compared among matched patients using a linear regression model; intraoperative transfusion requirement in volume of red blood cells, fresh frozen plasma, platelet, cryoprecipitate, cell salvaged blood, volume of intraoperative infusion of hetastarch, 5% albumin, crystalloids, and hospital length of hospital (LOS) were compared using Wilcoxon rank-sum tests. MAIN
RESULTS: Intraoperative EBL and requirement of blood product transfusion were similar in patients with Type O blood group and those with other blood groups.
CONCLUSION: There was no association between Type O blood and increased intraoperative blood loss or blood transfusion requirement during extensive spine surgery, with similar hospital LOS in Type O and non-O patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood loss, surgical; Blood salvage, intraoperative; Hemodilution; Transfusion; Type O blood

Mesh:

Substances:

Year:  2014        PMID: 25172503      PMCID: PMC4786074          DOI: 10.1016/j.jclinane.2014.01.019

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  14 in total

1.  Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels.

Authors:  James O'Donnell; Frank E Boulton; Richard A Manning; Michael A Laffan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-02-01       Impact factor: 8.311

Review 2.  An international view of hydroxyethyl starches.

Authors:  J Treib; J F Baron; M T Grauer; R G Strauss
Journal:  Intensive Care Med       Date:  1999-03       Impact factor: 17.440

Review 3.  Coagulation disorders caused by hydroxyethyl starch.

Authors:  J Treib; A Haass; G Pindur
Journal:  Thromb Haemost       Date:  1997-09       Impact factor: 5.249

4.  Changes in blood coagulation during and following cardiopulmonary bypass: lack of correlation with clinical bleeding.

Authors:  A B Gelb; R I Roth; J Levin; M J London; R A Noall; W W Hauck; M Cloutier; E Verrier; D T Mangano
Journal:  Am J Clin Pathol       Date:  1996-07       Impact factor: 2.493

5.  The hemostatic profiles of patients with Type O and non-O blood after acute normovolemic hemodilution with 6% hydroxyethyl starch (130/0.4).

Authors:  Jin Gu Kang; Hyun Joo Ahn; Gaab Soo Kim; Tae Soo Hahm; Jeong Jin Lee; Mi Sook Gwak; Soo Joo Choi
Journal:  Anesth Analg       Date:  2006-12       Impact factor: 5.108

6.  ABO blood group and bleeding after coronary artery bypass graft surgery.

Authors:  Ian J Welsby; Robert Jones; John Pylman; Jonathan B Mark; Charles S Brudney; Barbara Phillips-Bute; Joseph P Mathew; Mary Lee Campbell; Mark Stafford-Smith
Journal:  Blood Coagul Fibrinolysis       Date:  2007-12       Impact factor: 1.276

7.  Comparison of coagulation factors and blood loss between O and non-O blood types following hydroxyethyl starch infusion.

Authors:  Soo Joo Choi; Hyun Joo Ahn; Jae Ik Lee
Journal:  Korean J Anesthesiol       Date:  2010-04-28

8.  ABO blood group genotype and plasma von Willebrand factor in normal individuals.

Authors:  M Shima; Y Fujimura; T Nishiyama; T Tsujiuchi; N Narita; T Matsui; K Titani; M Katayama; F Yamamoto; A Yoshioka
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

9.  The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study.

Authors:  R E Collis; P W Collins; C N Gutteridge; A Kaul; A C Newland; D M Williams; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

10.  ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).

Authors:  T Ohira; M Cushman; M Y Tsai; Y Zhang; S R Heckbert; N A Zakai; W D Rosamond; A R Folsom
Journal:  J Thromb Haemost       Date:  2007-04-09       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.